Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Endocare Cryocare

This article was originally published in The Gray Sheet

Executive Summary

Cardiac surgical system cleared via 510(k) Aug. 3 uses cryoablation technology to treat arrhythmias including atrial fibrillation. The device uses specially designed malleable cryoprobes to create long linear lesions through the heart wall to block abberant electrical signals, the firm explains

You may also be interested in...

CryoCath/Endocare Deal Aimed At Minimally Invasive Cardiac Surgery Market

CryoCath anticipates that its five-year exclusive global supply and market access agreement with Endocare will allow for the development of a cryoablation device that can be used in keyhole surgery.

Coronavirus Notebook: UK On Cusp Of First Vaccine Approval, Moderna To File mRNA-1273 in US & EU

Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts